Noninvasive Hair Rejuvenation

Jordan Sand; Scott Walen

doi:10.1016/j.cps.2022.12.015

Noninvasive Hair Rejuvenation

Clin Plast Surg. 2023 Jul;50(3):509-520. doi: 10.1016/j.cps.2022.12.015.

Authors

Jordan Sand¹, Scott Walen²

Affiliations

¹ Spokane Center for Facial Plastic Surgery, 217 W. Cataldo Avenue, Spokane, WA 99201, USA.
² Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, The Pennsylvania State University, College of Medicine, 500 University Drive H-091, Hershey, PA 17033, USA. Electronic address: swalen1@pennstatehealth.psu.edu.

PMID: 37169416
DOI: 10.1016/j.cps.2022.12.015

Abstract

Both nonsurgical and surgical modalities for the treatment of hair loss are being used by providers at an increasing rate worldwide. Men and woman are affected by hair loss, but the pathophysiology of the hair loss is thought to be different between sexes; therefore, gender must play a role in treatment decisions. Currently, there are 3 Food and Drug Administration-approved nonsurgical androgenetic alopecia treatments: minoxidil, finasteride, and low-light laser therapy. Platelet-rich plasma injections are showing promise as a single modality and as an adjunct to other nonsurgical and surgical treatments of androgenetic alopecia.

Keywords: Androgenetic alopecia; Hair rejuvenation; Medical therapy; Platelet-rich plasma.

Publication types

Review

MeSH terms

Alopecia / drug therapy
Female
Finasteride / therapeutic use
Hair*
Humans
Male
Minoxidil / therapeutic use
Rejuvenation*
Treatment Outcome

Substances

Minoxidil
Finasteride